Explore evidence

82 %Among pregnant women with high HIV risk scores in Kenya, those who self-perceived low HIV risk declined PrEP at a rate of 82%, compared to 60% among those who self-perceived high HIV risk.

KenyaVIH/sidapublished 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations

16 sequencesThe largest pre-treatment HIV drug resistance transmission cluster in Kenya was a K103N cluster involving 16 men who have sex with men sequences sampled between 2010 and 2017.

KenyaVIH/sidaobserved 2010–2017published 2024The Journal of antimicrobial chemotherapyPubMeddocument of 7 observations

2,227 individualsThe study included 2227 HIV infected adults visiting health facilities in Nairobi and Busia, Kenya.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 7 observations

41.3 %Pre-treatment HIV drug resistance was most prevalent among perinatally infected children (41.3%), followed by people who inject drugs (31.0%), men who have sex with men (19.9%), female sex workers (15.1%), and heterosexuals (13.9%).

KenyaVIH/sidaobserved 1986–2020published 2024The Journal of antimicrobial chemotherapyPubMeddocument of 7 observations

0.2 %In a prospective study of HIV incidence in African women in Eswatini, Kenya, South Africa, and Zambia, false positive HIV results occurred at 96 visits (0.2%) out of 48,234 visits.

Afrique du Sud · Kenya · ZambieVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

336 individualsAmong 1136 people testing HIV-positive at 4 HIV testing and counseling clinics in Kenya from February 2015 to February 2016, 336 (30%) had never tested before.

KenyaVIH/sidaobserved February 2015 to February 2016published 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations

29.8 %Among viral failures on tenofovir disoproxil fumarate (TDF)-based regimens, 29.8% had zidovudine (AZT)-related drug resistance.

KenyaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

0.06 infants_identified_with_HIV_per_facility_per_monthThe mean monthly number of infants identified with HIV per health facility increased from 0.06 to 0.37.

KenyaVIH/sidaobserved October 2015 to September 2016published 2022AIDS carePubMeddocument of 16 observations

80 %Among 187 participants with second-line viral failure, NNRTI resistance prevalence was 80%.

KenyaVIH/sidaobserved 2011 to 2021published 2025Journal of the International AIDS SocietyPubMeddocument of 15 observations

90 %At 12 months after enrolment, 283 (90%) of 313 participants in the intervention group achieved virological suppression.

KenyaVIH/sidapublished 2022The Lancet. Child & adolescent healthPubMeddocument of 12 observations

27 %Among young females who sell sex (YFSS) living with HIV in Mombasa, Kenya, 27.0% were diagnosed and aware.

KenyaVIH/sidaobserved 2015published 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 11 observations

0.7 %Among Kenyan adolescents aged 15–19 years in Kisumu who did not experience forced sexual contact, 0.7% had used PrEP.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 15 observations

52 %52% (79) of partners in the HIVST strategy tested for HIV.

KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations

245 HIV-1 seroconvertersWe included 245 HIV-1 seroconverters and 713 controls from the serodiscordant couples cohorts.

KenyaVIH/sidapublished 2020Journal of the International AIDS SocietyPubMeddocument of 13 observations

88 %WebPSSMR5X4 and Geno2Pheno [G2P:10-15% false positive rate] showed high concordance of 88% in predicting HIV tropism.

KenyaVIH/sidapublished 2022MedicinePubMeddocument of 6 observations

83 %83% of participants were virally suppressed.

KenyaVIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 5 observations

13 minutesProviders spent 13 out of 54 minutes obtaining male sex partner contact information from HIV-negative clients during HIV testing services visits.

KenyaVIH/sidapublished 2022BMC health services researchPubMeddocument of 13 observations

29,856 per_1000000_testsClusters with a high number of newly diagnosed HIV-infected persons had 29,856 newly diagnosed HIV-positives per 1,000,000 tests in Kenya.

KenyaVIH/sidaobserved 2015-10-01 to 2016-09-30published 2021Frontiers in public healthPubMeddocument of 6 observations

0.31 per_100_person-yearsMaternal HIV incidence was 0.31 per 100 person-years in the Targeted arm.

KenyaVIH/sidapublished 2023Journal of the International AIDS SocietyPubMeddocument of 9 observations

69 %In Kenya, outpatient testing contributed 69% of the total number of children identified with HIV.

KenyaVIH/sidaobserved 2015–2016published 2020International journal of STD & AIDSPubMeddocument of 7 observations

50 %Among 10 enrollees who were unwilling to participate, five (50%) cited a fear of acquiring HIV.

KenyaVIH/sidaobserved From February 2017 to May 2018published 2026BMC public healthPubMeddocument of 10 observations

1.2 %Cumulative mortality incidence among children and adolescents initiating antiretroviral therapy in central Kenya was 1.2% at 24 months.

KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

3.3 odds_ratioHIV-exposed infants were 3.3 times more likely to belong to the length-for-age z-score growth class that remained at a z-score of < -2, indicating stunted growth.

KenyaVIH/sidapublished 2023The Journal of nutritionPubMeddocument of 3 observations

20 %Twenty percent of exposed health-care workers (n=83) took PEP against HIV.

KenyaVIH/sidaobserved preceding 12 monthspublished 2013Pan African Medical JournalOpenAlexdocument of 8 observations

198 infantsA total of 198 infants presented for care without receiving a point-of-care HIV test, representing missed opportunities for testing.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 13 observations